In the last year, the Top 30 Most Active Venture Capital Firms had their hands in one out of every four deals which amounted to nearly $9 billion in funding. Previously, we examined the activity of these firms in the internet and greentech/cleantech sectors. Now, we’ll take a look at the healthcare industry, which also fared quite well, receiving 26% of top 30 funding and 18% of their deals in 2009-2010.
Within healthcare, the medical devices & equipment and pharmaceuticals industries reigned supreme with a combined 63% of the Top 30’s investment. Holding their own, however, were the drug development and biotechnology industries, which took home 11% and 12%, respectively, of the sector’s dollars. These four industries account for almost 90% of the sector’s funding. In deal flow terms, the story is much the same: Medical devices & equipment (34%) and pharma (29%) maintain top spots, losing a couple of points to biotech (14%).
This report was created with data from CB Insights’ emerging technology insights platform, which offers clarity into emerging tech and new business strategies through tools like:
- Earnings Transcripts Search Engine & Analytics to get an information edge on competitors’ and incumbents’ strategies
- Patent Analytics to see where innovation is happening next
- Company Mosaic Scores to evaluate startup health, based on our National Science Foundation-backed algorithm
- Business Relationships to quickly see a company’s competitors, partners, and more
- Market Sizing Tools to visualize market growth and spot the next big opportunity